Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR)
Authors:
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 152 (1) , 456-462
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertensionLife Sciences, 1986
- Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR stroke-proneBiochemical and Biophysical Research Communications, 1986
- Biologically active atrial peptides.Journal of Clinical Investigation, 1985
- Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte HomeostasisNew England Journal of Medicine, 1985
- Atrial Natriuretic Factor: A Hormone Produced by the HeartScience, 1985
- Atrial natriuretic factor—a circulating hormone stimulated by volume loadingNature, 1985
- Inhibition of Aldosterone Production by an Atrial ExtractScience, 1984
- Atrial natriuretic factor: reduced cardiac content in spontaneously hypertensive rats.Hypertension, 1983
- Relationship of specific granules to the natriuretic and diuretic activity of rat atriaCellular and Molecular Life Sciences, 1982
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981